Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles

PURPOSE: Thymosin beta 4 (Tβ4) has multiple beneficial facets for myocardial injury, but its efficiency is limited by the low local concentration within the infarct. Here, we established a Tβ4 delivery system for cardiac repair based on the interaction between the abundant fibrin in the infarct zone...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zheyong, Song, Yanan, Pang, Zhiqing, Zhang, Bo, Yang, Hongbo, Shi, Hongtao, Chen, Jing, Gong, Hui, Qian, Juying, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396927/
https://www.ncbi.nlm.nih.gov/pubmed/28442910
http://dx.doi.org/10.2147/IJN.S131949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396927/
https://www.ncbi.nlm.nih.gov/pubmed/28442910
http://dx.doi.org/10.2147/IJN.S131949

Ejemplares similares